ENDOLOGIX INC's ticker is and the CUSIP is 29266SAB2. A total of 9 filers reported holding ENDOLOGIX INC in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $38,243,000 | +9.6% | 40,500,000 | 0.0% | 1.34% | +11.1% |
| Q1 2018 | $34,899,000 | -3.4% | 40,500,000 | 0.0% | 1.21% | -14.9% |
| Q4 2017 | $36,112,000 | +3.1% | 40,500,000 | 0.0% | 1.42% | -9.9% |
| Q3 2017 | $35,030,000 | +2.1% | 40,500,000 | 0.0% | 1.58% | -13.8% |
| Q2 2017 | $34,309,000 | -14.3% | 40,500,000 | 0.0% | 1.83% | +18.6% |
| Q1 2017 | $40,013,000 | +13.0% | 40,500,000 | 0.0% | 1.54% | +5.8% |
| Q4 2016 | $35,425,000 | -8.3% | 40,500,000 | +1.2% | 1.46% | -11.4% |
| Q1 2016 | $38,632,000 | +18.7% | 40,000,000 | +33.3% | 1.64% | +24.7% |
| Q4 2015 | $32,548,000 | – | 30,000,000 | – | 1.32% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Context Capital Management, LLC | 3,500,000 | $3,793,000 | 5.91% |
| FNY Managed Accounts LLC | 500,000 | $542,190,000 | 2.68% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 30,000,000 | $32,548,000 | 1.32% |
| ZAZOVE ASSOCIATES LLC | 13,906,000 | $15,123,000 | 0.71% |
| DAFNA Capital Management LLC | 500,000 | $545,000 | 0.49% |
| SSI INVESTMENT MANAGEMENT LLC | 4,000,000 | $4,308,000 | 0.44% |
| CAMDEN ASSET MANAGEMENT L P /CA | 9,100,000 | $9,868,000 | 0.31% |
| LINDEN ADVISORS LP | 4,500,000 | $4,896,000 | 0.30% |
| WOLVERINE ASSET MANAGEMENT LLC | 11,000,000 | $11,949,000 | 0.26% |
| PRELUDE CAPITAL MANAGEMENT, LLC | 300,000 | $327,000 | 0.05% |